pharmaphorum2d
Merck MS tablet set for wider use by NHS in England
The list price of Mavenclad is around £2,050 per 10mg tablet, although, Merck is providing it to the NHS in England at a ...
Take-at-home tablet for MS approved by NHS
The move will also “significantly free up clinical time” by reducing the need for hospital appointments, officials said. | ITV National News ...
Multiple sclerosis patients to benefit from pioneering 'take at home' tablet now approved for wider NHS rollout
The medication, which will be rolled out to patients with relapsing-remitting MS, is thought to be the first in Europe to be ...
STV News2d
Medicines regulator considers wider rollout of take-at-home tablet for MS
The Scottish Medicines Consortium is reviewing cladribine for broader use in relapsing forms of the condition.
pharmaphorum2d
Regulators finally back Merck KGaA oral MS drug
Europe’s CHMP top scientific committee gave a positive opinion for approval to cladribine, with the proposed trade name Mavenclad, for relapsing forms of MS with high disease activity.
FiercePharma22d
Merck KGaA's EMD Serono taps Selma Blair to join long-running campaign for MS drug Mavenclad
The "I’m Ready" campaign initially launched in the summer of 2021, two years after Mavenclad’s FDA approval ... from other MS infusions and daily pills by requiring only about 16 to 20 ...
Trade Arabia7mon
Merck's drug for multiple sclerosis wins UAE approval
US pharma group Merck said the UAE Ministry of Health and Prevention has approved the registration of its Mavenclad (cladribine tablets) for the treatment of adult patients with highly active ...